XML 46 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions - Summary of Total Consideration for Horizon Therapeutics plc (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Oct. 06, 2023
Business Acquisition [Line Items]      
Goodwill $ 18,570 $ 18,629  
Horizon Therapeutics      
Business Acquisition [Line Items]      
Cash and cash equivalents     $ 681
Inventories $ 5,000   5,025
Property, plant and equipment, net     318
IPR&D     1,060
Goodwill     3,062
Deferred tax asset     834
Deferred tax liability     (2,492)
Other assets and liabilities, net     (245)
Total assets acquired, net     27,833
Horizon Therapeutics | Developed-product-technology rights      
Business Acquisition [Line Items]      
Finite-lived intangible assets – developed-product-technology rights     $ 19,590